DMKJ
AUPH icon

David M. Knott Jr’s Aurinia Pharmaceuticals AUPH Stock Holding History

David M. Knott Jr’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-80,694
Closed -$607K – 173
2022
Q3 		$607K Hold
80,694
– – 0.26% 66
2022
Q2 		$811K Hold
80,694
– – 0.34% 54
2022
Q1 		$999K Buy
+80,694
New +$1.25M 0.32% 55

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

David M. Knott Jr's AUPH Position: Q4 2022 in Review

David M. Knott Jr sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 80,694 shares — an estimated $607K sold.

David M. Knott Jr first reported a position in AUPH in Q1 2022 and held it in 3 quarters. The position peaked at $999K in Q1 2022. 192 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

  • David M. Knott Jr reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • David M. Knott Jr sold 80,694 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $607K.
  • David M. Knott Jr first reported a position in Aurinia Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • David M. Knott Jr's Aurinia Pharmaceuticals position peaked at $999K in Q1 2022.
  • 192 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on David M. Knott Jr's 13F filing for Q4 2022, filed 13 Feb 2023.